Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04785079 · ClinicalTrials.gov registry record · NA
Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow
A NA study of Asymptomatic Condition, sponsored by Florida Gulf Coast University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04785079: Completed NA study of Asymptomatic Condition, sponsored by Florida Gulf Coast University.
NCT04785079 is a NA study of Asymptomatic Condition that has completed, run by Florida Gulf Coast University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04785079, a NA study of Asymptomatic Condition, has completed, sponsored by Florida Gulf Coast University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate the short term change in blood flow in the superficial human tissue layers after the application of 3 min Graston instrumented assisted soft tissue mobilization on the plantar aspect of the foot and the trapezius muscle.
Primary Outcome
ultrasound images are used to calculate the ratio of color to grey scale pixels called the power doppler quantification ratio (PDIQ).
Conditions Studied
Interventions
- PROCEDURE Graston Instrument assisted Soft tissue Mobilization
Study Locations (1)
Florida
- Florida Gulf Coast University - Fort Myers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT04785079 record still lists
NCT04785079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asymptomatic Condition appearing as the primary indexed condition, and to 1 intervention - of which Graston Instrument assisted Soft tissue Mobilization is the first listed.
NCT04785079 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04785079 about?
NCT04785079 is a clinical study titled "Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow". This study is designed to evaluate the short term change in blood flow in the superficial human tissue layers after the application of 3 min Graston instrumented assisted soft tissue mobilization on the plantar aspect of the foot and the trapezius muscle.
What is the current status of trial NCT04785079?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-08-01. Estimated completion is 2022-03-01.
What conditions does trial NCT04785079 study?
This clinical trial studies the following conditions: Asymptomatic Condition.
What interventions are being tested in trial NCT04785079?
The interventions under investigation include: Graston Instrument assisted Soft tissue Mobilization (PROCEDURE).
Who is sponsoring clinical trial NCT04785079?
This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04785079 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04785079's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI